The FDAs Pharmacy Compounding Advisory Committee backed BPC-157, KPV and TB-500 by 8 to 6 with one abstention, and MOTS-c by 7 to 5 with two abstentions, according to Pharmaceutical Executives tally of the meeting
IV administration bypasses digestion, but this does not establish better clinical outcomes for general wellness, detoxification or longevity
Breastfeeding safety depends on every fluid, nutrient, medication, dose, and maternal condition
GLP-1 agonists commonly cause nausea, vomiting, and gastrointestinal distress, particularly during dose escalation
Ajoolabady, A., Lindholm, D., Ren, J